As of Monday, December 08, Quince Therapeutics, Inc.’s QNCX share price has dipped by 7.48%, which has investors questioning if this is right time to buy.

The FDA has approved the Vanquish Water Vapor Ablation System, which uses steam to destroy prostate tumors. However, the ...

Senior AI editor Will Douglas Heaven talks with Tim Bradshaw, FT global tech correspondent, about what our world will look ...

Antisemitism continues to run amok across American college campuses, with some of the top universities in the nation failing ...

Discover the iPhone 18 Pro Max’s 6 key upgrades, including new colors, better battery, satellite connectivity, and ...